Screener
ClearPoint Neuro CLPT Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Interest expense | (1,382) | — |
| Net loss before income taxes | (9,544) | (6,008) |
| Income tax expense | 8 | 18 |
| Net loss | $(9,552) | $(6,026) |
| Net loss per share attributable to common stockholders: | ||
| Basic and diluted | $(0.32) | $(0.22) |
| Weighted average shares outstanding: | ||
| Basic and diluted | 29,546,889 | 27,718,918 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's net income?
- ClearPoint Neuro (CLPT) reported net income of -$9.55M in Q1 2026.
- How has ClearPoint Neuro's net income changed year-over-year?
- ClearPoint Neuro's net income decreased by 58.5% year-over-year, from -$6.03M to -$9.55M.
- What is the long-term trend for ClearPoint Neuro's net income?
- Over 4 years (2021 to 2025), ClearPoint Neuro's net income has grown at a 15.4% compound annual growth rate (CAGR), from -$14.41M to -$25.54M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about ClearPoint Neuro's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude